BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 30967876)

  • 1. Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme.
    Lee M; Park C; Woo J; Kim J; Kho I; Nam DH; Park WY; Kim YS; Kong DS; Lee HW; Kim TJ
    Front Immunol; 2019; 10():555. PubMed ID: 30967876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Cell Carcinoma-Infiltrating CD3
    Lee HW; Park C; Joung JG; Kang M; Chung YS; Oh WJ; Yeom SY; Park WY; Kim TJ; Seo SI
    Curr Issues Mol Biol; 2021 May; 43(1):226-239. PubMed ID: 34071865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes.
    Mohme M; Schliffke S; Maire CL; Rünger A; Glau L; Mende KC; Matschke J; Gehbauer C; Akyüz N; Zapf S; Holz M; Schaper M; Martens T; Schmidt NO; Peine S; Westphal M; Binder M; Tolosa E; Lamszus K
    Clin Cancer Res; 2018 Sep; 24(17):4187-4200. PubMed ID: 29444930
    [No Abstract]   [Full Text] [Related]  

  • 4. Human liver infiltrating γδ T cells are composed of clonally expanded circulating and tissue-resident populations.
    Hunter S; Willcox CR; Davey MS; Kasatskaya SA; Jeffery HC; Chudakov DM; Oo YH; Willcox BE
    J Hepatol; 2018 Sep; 69(3):654-665. PubMed ID: 29758330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma cells potentiate the induction of the Th1-like profile in phosphoantigen-stimulated γδ T lymphocytes.
    Rosso DA; Rosato M; Iturrizaga J; González N; Shiromizu CM; Keitelman IA; Coronel JV; Gómez FD; Amaral MM; Rabadan AT; Salamone GV; Jancic CC
    J Neurooncol; 2021 Jul; 153(3):403-415. PubMed ID: 34125375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKG2D Controls Natural Reactivity of Vγ9Vδ2 T Lymphocytes against Mesenchymal Glioblastoma Cells.
    Chauvin C; Joalland N; Perroteau J; Jarry U; Lafrance L; Willem C; Retière C; Oliver L; Gratas C; Gautreau-Rolland L; Saulquin X; Vallette FM; Vié H; Scotet E; Pecqueur C
    Clin Cancer Res; 2019 Dec; 25(23):7218-7228. PubMed ID: 31506386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients.
    Viey E; Lucas C; Romagne F; Escudier B; Chouaib S; Caignard A
    J Immunother; 2008 Apr; 31(3):313-23. PubMed ID: 18317356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCR repertoire analysis reveals phosphoantigen-induced polyclonal proliferation of Vγ9Vδ2 T cells in neonates and adults.
    Fichtner AS; Bubke A; Rampoldi F; Wilharm A; Tan L; Steinbrück L; Schultze-Florey C; von Kaisenberg C; Prinz I; Herrmann T; Ravens S
    J Leukoc Biol; 2020 Jun; 107(6):1023-1032. PubMed ID: 32064671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma.
    Woroniecka K; Chongsathidkiet P; Rhodin K; Kemeny H; Dechant C; Farber SH; Elsamadicy AA; Cui X; Koyama S; Jackson C; Hansen LJ; Johanns TM; Sanchez-Perez L; Chandramohan V; Yu YA; Bigner DD; Giles A; Healy P; Dranoff G; Weinhold KJ; Dunn GP; Fecci PE
    Clin Cancer Res; 2018 Sep; 24(17):4175-4186. PubMed ID: 29437767
    [No Abstract]   [Full Text] [Related]  

  • 10. Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme.
    Bryant NL; Gillespie GY; Lopez RD; Markert JM; Cloud GA; Langford CP; Arnouk H; Su Y; Haines HL; Suarez-Cuervo C; Lamb LS
    J Neurooncol; 2011 Jan; 101(2):179-88. PubMed ID: 20532954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells.
    Knight A; Arnouk H; Britt W; Gillespie GY; Cloud GA; Harkins L; Su Y; Lowdell MW; Lamb LS
    PLoS One; 2013; 8(8):e68729. PubMed ID: 23950874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the diversity of T cell receptor γδ complementary determinant region 3 in human peripheral blood by Immune Repertoire Sequencing.
    Chen H; Zou M; Teng D; Zhang J; He W
    J Immunol Methods; 2017 Apr; 443():9-17. PubMed ID: 28159550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma.
    Bryant NL; Suarez-Cuervo C; Gillespie GY; Markert JM; Nabors LB; Meleth S; Lopez RD; Lamb LS
    Neuro Oncol; 2009 Aug; 11(4):357-67. PubMed ID: 19211933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis.
    Wakita D; Sumida K; Iwakura Y; Nishikawa H; Ohkuri T; Chamoto K; Kitamura H; Nishimura T
    Eur J Immunol; 2010 Jul; 40(7):1927-37. PubMed ID: 20397212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γδ T-cell Receptors Derived from Breast Cancer-Infiltrating T Lymphocytes Mediate Antitumor Reactivity.
    Janssen A; Villacorta Hidalgo J; Beringer DX; van Dooremalen S; Fernando F; van Diest E; Terrizi AR; Bronsert P; Kock S; Schmitt-Gräff A; Werner M; Heise K; Follo M; Straetemans T; Sebestyen Z; Chudakov DM; Kasatskaya SA; Frenkel FE; Ravens S; Spierings E; Prinz I; Küppers R; Malkovsky M; Fisch P; Kuball J
    Cancer Immunol Res; 2020 Apr; 8(4):530-543. PubMed ID: 32019779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically Induced Tumors in the Oncopig Model Invoke an Antitumor Immune Response Dominated by Cytotoxic CD8β
    Overgaard NH; Principe DR; Schachtschneider KM; Jakobsen JT; Rund LA; Grippo PJ; Schook LB; Jungersen G
    Front Immunol; 2018; 9():1301. PubMed ID: 29930558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and functions of γδ T cells infiltrated in the ovarian cancer microenvironment.
    Chen X; Shang W; Xu R; Wu M; Zhang X; Huang P; Wang F; Pan S
    J Transl Med; 2019 May; 17(1):144. PubMed ID: 31064389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-21 Increases the Reactivity of Allogeneic Human Vγ9Vδ2 T Cells Against Primary Glioblastoma Tumors.
    Joalland N; Chauvin C; Oliver L; Vallette FM; Pecqueur C; Jarry U; Scotet E
    J Immunother; 2018 Jun; 41(5):224-231. PubMed ID: 29683891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling the pattern of the human T-cell receptor γδ complementary determinant region 3 repertoire in patients with lung carcinoma via high-throughput sequencing analysis.
    Chen H; Zou M; Teng D; Hu Y; Zhang J; He W
    Cell Mol Immunol; 2019 Mar; 16(3):250-259. PubMed ID: 30886423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of tumor-infiltrating gamma delta T cells in rectal cancer.
    Rong L; Li K; Li R; Liu HM; Sun R; Liu XY
    World J Gastroenterol; 2016 Apr; 22(13):3573-80. PubMed ID: 27053849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.